Series A round brings $21mm to Antengene

14:40 EST 3 Jan 2019 | Elsevier Business Intelligence

Qiming Capital led a $21mm Series A round for cancer and infectious disease-focused Antengene Corp. Huagai Capital, Tigermed ...

Original Article: Series A round brings $21mm to Antengene

More From BioPortfolio on "Series A round brings $21mm to Antengene"